Accueil   Diary - News   All news Lyonbiopole, partner of the newly launched MAGIA project

Lyonbiopole, partner of the newly launched MAGIA project


The MAGIA project brings together four European leading Medtech and Health clusters – BioPmed (Piedmont), BioWin (Wallonia), Life Science Nord (Northern Germany) and Lyonbiopole (Auvergne-Rhône-Alpes) – willing to foster and support the Medtech SME’s internationalisation through the creation of a strong and sustainable Medtech Alliance.

The overall goal of the project is to provide support to the European Medtech SMEs to go international on two global target markets and to make the European Medtech industry more visible at the international level.

The Medtech Alliance aims to build a strong mutual understanding among the 4 clusters by identifying their assets and synergies in order to strengthen their collaboration.

In this respect, 4 cluster study visits are planned in the next months, as well as working groups involving SMEs to assess their internationalisation needs and to identify the two most relevant target markets. To better address the foreign markets that will be selected, a series of intelligence and training actions dedicated to SMEs will be performed.

Based on all these activities, the partners will have the necessary information to develop a common sound and realistic internationalisation strategy to provide added value for the SMEs as well as for the competitiveness of the Medtech sector in Europe.


About MAGIA:

MAGIA is the European Strategic Cluster Partnerships – Going International (ESCPs-4i) on medical technologies labelled and co-funded by the European Commission, DG Growth and the Executive Agency for SMEs of the European Commission following the COSME call COSCLUSINT-2016-03-01.

MAGIA is a transnational cluster partnership that develops and implements a joint internationalisation strategy and supports SME internationalisation towards third countries beyond Europe. It aims to develop common actions and an implementation roadmap as part of a long-term cooperation agenda.
Learn more on:


About Lyonbiopôle:

As a biocluster, Lyonbiopole is the one-stop shop for healthcare innovation in Rhône-Alpes, France. It aims to support the emergence and development of innovative technologies, products and services in 4 main strategic areas: human medicine, veterinary medicine, in vitro diagnostics, medical devices and medical technologies. Focused on infectious diseases since its creation in 2005, Lyonbiopole is now supporting ambitious projects and companies in other fields like cancer, nutrition, metabolic diseases and neurosciences. In 2014, Lyonbiopole represented a community of 176 members: 4 world-class leaders as Lyonbiopole’s founders (Sanofi Pasteur, bioMérieux, Merial, BD) – 18 Research Centers including 3 Hospital University Centers and almost 154 SMEs.

More information:

Press Contacts
Marie Tissier - + 33 4 72 40 54 10 - + 33 6 15 39 59 65 –
Marine Lefebvre - +33 4 72 40 54 10 –
Stéphanie Pelege – Responsable Communication Lyonbiopôle – 33 4 72 76 53 41